Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $1.53 billion. The enterprise value is $1.33 billion.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 411.96 million shares outstanding. The number of shares has increased by 23.28% in one year.
| Current Share Class | 411.96M |
| Shares Outstanding | 411.96M |
| Shares Change (YoY) | +23.28% |
| Shares Change (QoQ) | +11.79% |
| Owned by Insiders (%) | 7.18% |
| Owned by Institutions (%) | 56.89% |
| Float | 353.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.98 |
| Forward PS | 3.80 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.20 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.50% and return on invested capital (ROIC) is -32.82%.
| Return on Equity (ROE) | -55.50% |
| Return on Assets (ROA) | -27.30% |
| Return on Invested Capital (ROIC) | -32.82% |
| Return on Capital Employed (ROCE) | -51.39% |
| Weighted Average Cost of Capital (WACC) | 8.06% |
| Revenue Per Employee | $270,258 |
| Profits Per Employee | -$401,003 |
| Employee Count | 975 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 3.36 |
Taxes
| Income Tax | -2.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.20% in the last 52 weeks. The beta is 0.74, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +5.20% |
| 50-Day Moving Average | 3.20 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 49.06 |
| Average Volume (20 Days) | 22,854,367 |
Short Selling Information
The latest short interest is 130.93 million, so 31.78% of the outstanding shares have been sold short.
| Short Interest | 130.93M |
| Short Previous Month | 131.33M |
| Short % of Shares Out | 31.78% |
| Short % of Float | 37.05% |
| Short Ratio (days to cover) | 8.93 |
Income Statement
In the last 12 months, IOVA had revenue of $263.50 million and -$390.98 million in losses. Loss per share was -$1.09.
| Revenue | 263.50M |
| Gross Profit | 90.32M |
| Operating Income | -398.21M |
| Pretax Income | -393.05M |
| Net Income | -390.98M |
| EBITDA | -362.27M |
| EBIT | -398.21M |
| Loss Per Share | -$1.09 |
Full Income StatementBalance Sheet
The company has $296.98 million in cash and $49.44 million in debt, with a net cash position of $247.54 million or $0.60 per share.
| Cash & Cash Equivalents | 296.98M |
| Total Debt | 49.44M |
| Net Cash | 247.54M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 698.58M |
| Book Value Per Share | 1.70 |
| Working Capital | 304.33M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$302.41 million and capital expenditures -$33.84 million, giving a free cash flow of -$336.24 million.
| Operating Cash Flow | -302.41M |
| Capital Expenditures | -33.84M |
| Depreciation & Amortization | 35.94M |
| Net Borrowing | n/a |
| Free Cash Flow | -336.24M |
| FCF Per Share | -$0.82 |
Full Cash Flow StatementMargins
Gross margin is 34.28%, with operating and profit margins of -151.12% and -148.38%.
| Gross Margin | 34.28% |
| Operating Margin | -151.12% |
| Pretax Margin | -149.16% |
| Profit Margin | -148.38% |
| EBITDA Margin | -137.48% |
| EBIT Margin | -151.12% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.28% |
| Shareholder Yield | -23.28% |
| Earnings Yield | -24.81% |
| FCF Yield | -21.34% |
Analyst Forecast
The average price target for IOVA is $9.11, which is 144.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.11 |
| Price Target Difference | 144.89% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 27.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of -2.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.13 |
| Piotroski F-Score | 2 |
